The importance of cellular DREAM in regulating A20 expression was further confirmed by DREAM knockdown in SSc fibroblasts, which resulted in augmented A20 and reduced collagen levels and myofibroblast markers. This evidence concerns the gene TNFAIP3 and systemic sclerosis.